Kaapa Biotech launches the Nordic Mushrooms line

The Finnish company has signed a distribution agreement in North America

Kääpä Biotech has announced the launch of its Nordic Mushrooms product line.

In the North American market, the products will be distributed by Nutralliance, and the company is looking for partner opportunities in other markets.

Kääpä Biotech has invested in ultrasonic assisted extraction technology to produce its mushroom extracts, which employs a combination of hot water and alcohol extraction. The method aims to ensure the bio-availability of the desired bioactive compounds in each mushroom. Without an extraction process the compounds of interest are locked within the mushroom cell wall and pass through the human digestive system.

The Nordic Mushrooms wholesale mushroom extract product line includes Finnish grown organic chaga (Inonotus obliquus), reishi (Ganoderma lucidum), shiitake (Lentinula edodes), cordyceps (Cordyceps militaris), lion’s mane (Hericium erinaceus), maitake (Grifola frondosa) and turkey tail (Trametes versicolor). The product line includes mushroom extract powders and liquid extract ingredients for the health food and animal food supplement industry.

“There is an increased demand for high-quality medicinal mushroom products in the North American market area,” said Eric Puro, the CEO of Kääpä Biotech. “The origin of the ingredients used in the food supplement industry is also getting more important all the time. Our products are 100% of Finnish origin, from the FSC or PEFC certified Finnish sawdust substrate, to growing of mushrooms as well as processing and manufacturing of the mushroom extracts. We have full traceability and transparency in our process from spore to shipment. Therefore we can guarantee premium quality mushroom extracts to the market.”

“The fungi kingdom and especially members of the Basidiomycota phylum (mushrooms) hold tremendous potential for natural, safe and effective products that support a wide variety of health concerns as well as general well-being,” said Brian Salerno, CEO of Nutralliance. “To adequately fulfill modern North American consumers’ desires for superior quality in efficacy, safety and traceability as well as sustainability, we wanted to ensure our mycological expert source was able to put checkmarks in all those columns. Kääpä Biotech is that resource.”